PD-1/PD-L1 Inhibitors for Weight Loss - Global and China Top Players Market Share and Ranking 2023
This report studies and analyses global PD-1/PD-L1 Inhibitors for Weight Loss status and future trends, helps the client to determine the PD-1/PD-L1 Inhibitors for Weight Loss market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for PD-1/PD-L1 Inhibitors for Weight Loss, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global PD-1/PD-L1 Inhibitors for Weight Loss market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global PD-1/PD-L1 Inhibitors for Weight Loss sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China PD-1/PD-L1 Inhibitors for Weight Loss sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global PD-1/PD-L1 Inhibitors for Weight Loss key consuming regions, consumption quantity, consumption value and demand structure
(5) Global PD-1/PD-L1 Inhibitors for Weight Loss key producing regions, capacity, production, and year over year growth
(6) PD-1/PD-L1 Inhibitors for Weight Loss industry chains, upstream, midstream and downstream
According to Latest Research, the global market for PD-1/PD-L1 Inhibitors for Weight Loss should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China PD-1/PD-L1 Inhibitors for Weight Loss market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States PD-1/PD-L1 Inhibitors for Weight Loss market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Woman grew percent to account for percent of the total market sales, and Man grew percent.
Key Players Driving the Market:
Merck
Bristol-Myers Squibb
Roche
AstraZeneca
Ono Pharmaceutical
Regeneron
Innovent
Hengrui Medicine
Junshi Biosciences
Merck KGaA
By Product Type, the market is primarily segmented into:
PD-1 Inhibitors
PD-L1 Inhibitors
By Applications, the market is segmented into:
Woman
Man
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
The Report Consists of The Following Points:
Chapter 1: to describe PD-1/PD-L1 Inhibitors for Weight Loss product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global PD-1/PD-L1 Inhibitors for Weight Loss market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China PD-1/PD-L1 Inhibitors for Weight Loss market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of PD-1/PD-L1 Inhibitors for Weight Loss, percent & CAGR, 2018-2029
Chapter 5: PD-1/PD-L1 Inhibitors for Weight Loss industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 PD-1/PD-L1 Inhibitors for Weight Loss Definition
1.2 Global PD-1/PD-L1 Inhibitors for Weight Loss Market Size and Forecast
1.2.1 By Consumption Value, Global PD-1/PD-L1 Inhibitors for Weight Loss Market Size，2018-2029
1.2.2 By Sales Quantity, Global PD-1/PD-L1 Inhibitors for Weight Loss Market Size，2018-2029
1.2.3 Global PD-1/PD-L1 Inhibitors for Weight Loss Average Selling Price (ASP)，2018-2029
1.3 China PD-1/PD-L1 Inhibitors for Weight Loss Market Size and Forecast
1.3.1 By Consumption Value, China PD-1/PD-L1 Inhibitors for Weight Loss Market Size，2018-2029
1.3.2 By Sales Quantity, China PD-1/PD-L1 Inhibitors for Weight Loss Market Size，2018-2029
1.3.3 China PD-1/PD-L1 Inhibitors for Weight Loss Average Selling Price (ASP)， 2018-2029
1.4 Share of China PD-1/PD-L1 Inhibitors for Weight Loss Market with Respect to the Global Market
1.4.1 By Consumption Value, China PD-1/PD-L1 Inhibitors for Weight Loss Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China PD-1/PD-L1 Inhibitors for Weight Loss Market Share in Global, 2018-2029
1.4.3 PD-1/PD-L1 Inhibitors for Weight Loss Market Size: China VS Global, 2018-2029
1.5 PD-1/PD-L1 Inhibitors for Weight Loss Market Dynamics
1.5.1 PD-1/PD-L1 Inhibitors for Weight Loss Market Drivers
1.5.2 PD-1/PD-L1 Inhibitors for Weight Loss Market Restraints
1.5.3 PD-1/PD-L1 Inhibitors for Weight Loss Industry Trends
1.5.4 PD-1/PD-L1 Inhibitors for Weight Loss Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of PD-1/PD-L1 Inhibitors for Weight Loss, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of PD-1/PD-L1 Inhibitors for Weight Loss, Global Market Share by Company, 2018-2023
2.3 PD-1/PD-L1 Inhibitors for Weight Loss Average Selling Price (ASP) by Company, 2018-2023
2.4 Global PD-1/PD-L1 Inhibitors for Weight Loss Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global PD-1/PD-L1 Inhibitors for Weight Loss Concentration Ratio
2.6 Global PD-1/PD-L1 Inhibitors for Weight Loss Mergers & Acquisitions, Expansion Plans
2.7 Global PD-1/PD-L1 Inhibitors for Weight Loss Manufacturers Product Type
2.8 Head Office and PD-1/PD-L1 Inhibitors for Weight Loss Production Site of Key Manufacturer
2.9 PD-1/PD-L1 Inhibitors for Weight Loss Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of PD-1/PD-L1 Inhibitors for Weight Loss, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of PD-1/PD-L1 Inhibitors for Weight Loss, China Market Share by Company, 2018-2023
3.3 China PD-1/PD-L1 Inhibitors for Weight Loss Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global PD-1/PD-L1 Inhibitors for Weight Loss Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global PD-1/PD-L1 Inhibitors for Weight Loss Capacity by Region
4.3 Global PD-1/PD-L1 Inhibitors for Weight Loss Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global PD-1/PD-L1 Inhibitors for Weight Loss Production by Region, 2018-2029
4.5 Global PD-1/PD-L1 Inhibitors for Weight Loss Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 PD-1/PD-L1 Inhibitors for Weight Loss Industry Chain
5.2 PD-1/PD-L1 Inhibitors for Weight Loss Upstream Analysis
5.2.1 PD-1/PD-L1 Inhibitors for Weight Loss Core Raw Materials
5.2.2 Main Manufacturers of PD-1/PD-L1 Inhibitors for Weight Loss Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 PD-1/PD-L1 Inhibitors for Weight Loss Production Mode
5.6 PD-1/PD-L1 Inhibitors for Weight Loss Procurement Model
5.7 PD-1/PD-L1 Inhibitors for Weight Loss Industry Sales Model and Sales Channels
5.7.1 PD-1/PD-L1 Inhibitors for Weight Loss Sales Model
5.7.2 PD-1/PD-L1 Inhibitors for Weight Loss Typical Distributors
6 Sights by Type
6.1 PD-1/PD-L1 Inhibitors for Weight Loss Classification
6.1.1 PD-1 Inhibitors
6.1.2 PD-L1 Inhibitors
6.2 By Type, Global PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value, 2018-2029
6.4 By Type, Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, 2018-2029
6.5 By Type, Global PD-1/PD-L1 Inhibitors for Weight Loss Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 PD-1/PD-L1 Inhibitors for Weight Loss Segment by Application
7.1.1 Woman
7.1.2 Man
7.2 By Application, Global PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value, 2018-2029
7.4 By Application, Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, 2018-2029
7.5 By Application, Global PD-1/PD-L1 Inhibitors for Weight Loss Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value, 2018-2029
8.3 By Region, Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America PD-1/PD-L1 Inhibitors for Weight Loss & Forecasts, 2018-2029
8.4.2 By Country, North America PD-1/PD-L1 Inhibitors for Weight Loss Market Size Market Share
8.5 Europe
8.5.1 Europe PD-1/PD-L1 Inhibitors for Weight Loss Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe PD-1/PD-L1 Inhibitors for Weight Loss Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific PD-1/PD-L1 Inhibitors for Weight Loss Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific PD-1/PD-L1 Inhibitors for Weight Loss Market Size Market Share
8.7 South America
8.7.1 South America PD-1/PD-L1 Inhibitors for Weight Loss Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America PD-1/PD-L1 Inhibitors for Weight Loss Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global PD-1/PD-L1 Inhibitors for Weight Loss Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value, 2018-2029
9.3 By Country, Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. PD-1/PD-L1 Inhibitors for Weight Loss Market Size, 2018-2029
9.4.2 By Type, U.S. PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe PD-1/PD-L1 Inhibitors for Weight Loss Market Size, 2018-2029
9.5.2 By Type, Europe PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China PD-1/PD-L1 Inhibitors for Weight Loss Market Size, 2018-2029
9.6.2 By Type, China PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan PD-1/PD-L1 Inhibitors for Weight Loss Market Size, 2018-2029
9.7.2 By Type, Japan PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea PD-1/PD-L1 Inhibitors for Weight Loss Market Size, 2018-2029
9.8.2 By Type, South Korea PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia PD-1/PD-L1 Inhibitors for Weight Loss Market Size, 2018-2029
9.9.2 By Type, Southeast Asia PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India PD-1/PD-L1 Inhibitors for Weight Loss Market Size, 2018-2029
9.10.2 By Type, India PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa PD-1/PD-L1 Inhibitors for Weight Loss Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Merck
10.1.1 Merck Company Information, Head Office, Market Area, and Industry Position
10.1.2 Merck PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications, and Application
10.1.3 Merck PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Merck Company Profile and Main Business
10.1.5 Merck Recent Developments
10.2 Bristol-Myers Squibb
10.2.1 Bristol-Myers Squibb Company Information, Head Office, Market Area, and Industry Position
10.2.2 Bristol-Myers Squibb PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications, and Application
10.2.3 Bristol-Myers Squibb PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Bristol-Myers Squibb Company Profile and Main Business
10.2.5 Bristol-Myers Squibb Recent Developments
10.3 Roche
10.3.1 Roche Company Information, Head Office, Market Area, and Industry Position
10.3.2 Roche PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications, and Application
10.3.3 Roche PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Roche Company Profile and Main Business
10.3.5 Roche Recent Developments
10.4 AstraZeneca
10.4.1 AstraZeneca Company Information, Head Office, Market Area, and Industry Position
10.4.2 AstraZeneca PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications, and Application
10.4.3 AstraZeneca PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 AstraZeneca Company Profile and Main Business
10.4.5 AstraZeneca Recent Developments
10.5 Ono Pharmaceutical
10.5.1 Ono Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.5.2 Ono Pharmaceutical PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications, and Application
10.5.3 Ono Pharmaceutical PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Ono Pharmaceutical Company Profile and Main Business
10.5.5 Ono Pharmaceutical Recent Developments
10.6 Regeneron
10.6.1 Regeneron Company Information, Head Office, Market Area, and Industry Position
10.6.2 Regeneron PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications, and Application
10.6.3 Regeneron PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Regeneron Company Profile and Main Business
10.6.5 Regeneron Recent Developments
10.7 Innovent
10.7.1 Innovent Company Information, Head Office, Market Area, and Industry Position
10.7.2 Innovent PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications, and Application
10.7.3 Innovent PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Innovent Company Profile and Main Business
10.7.5 Innovent Recent Developments
10.8 Hengrui Medicine
10.8.1 Hengrui Medicine Company Information, Head Office, Market Area, and Industry Position
10.8.2 Hengrui Medicine PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications, and Application
10.8.3 Hengrui Medicine PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Hengrui Medicine Company Profile and Main Business
10.8.5 Hengrui Medicine Recent Developments
10.9 Junshi Biosciences
10.9.1 Junshi Biosciences Company Information, Head Office, Market Area, and Industry Position
10.9.2 Junshi Biosciences PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications, and Application
10.9.3 Junshi Biosciences PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Junshi Biosciences Company Profile and Main Business
10.9.5 Junshi Biosciences Recent Developments
10.10 Merck KGaA
10.10.1 Merck KGaA Company Information, Head Office, Market Area, and Industry Position
10.10.2 Merck KGaA PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications, and Application
10.10.3 Merck KGaA PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Merck KGaA Company Profile and Main Business
10.10.5 Merck KGaA Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. PD-1/PD-L1 Inhibitors for Weight Loss Market Restraints
Table 3. PD-1/PD-L1 Inhibitors for Weight Loss Market Trends
Table 4. PD-1/PD-L1 Inhibitors for Weight Loss Industry Policy
Table 5. Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global PD-1/PD-L1 Inhibitors for Weight Loss Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global PD-1/PD-L1 Inhibitors for Weight Loss Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global PD-1/PD-L1 Inhibitors for Weight Loss Mergers & Acquisitions, Expansion Plans
Table 12. Global PD-1/PD-L1 Inhibitors for Weight Loss Manufacturers Product Type
Table 13. Head Office and PD-1/PD-L1 Inhibitors for Weight Loss Production Site of Key Manufacturer
Table 14. PD-1/PD-L1 Inhibitors for Weight Loss Capacity of Major Manufacturers and Future Plan
Table 15. China PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global PD-1/PD-L1 Inhibitors for Weight Loss Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global PD-1/PD-L1 Inhibitors for Weight Loss Production by Region, 2018-2023, (K Units)
Table 20. Global PD-1/PD-L1 Inhibitors for Weight Loss Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of PD-1/PD-L1 Inhibitors for Weight Loss Upstream (Raw Materials)
Table 22. Global PD-1/PD-L1 Inhibitors for Weight Loss Typical Customers
Table 23. PD-1/PD-L1 Inhibitors for Weight Loss Typical Distributors
Table 24. By Type, Global PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value Market Share, 2018-2029
Table 32. By Country, Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity Market Share, 2018-2029
Table 34. Merck Company Information, Head Office, Market Area, and Industry Position
Table 35. Merck PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications, and Application
Table 36. Merck PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Merck Company Profile and Main Business
Table 38. Merck Recent Developments
Table 39. Bristol-Myers Squibb Company Information, Head Office, Market Area, and Industry Position
Table 40. Bristol-Myers Squibb PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications, and Application
Table 41. Bristol-Myers Squibb PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Bristol-Myers Squibb Company Profile and Main Business
Table 43. Bristol-Myers Squibb Recent Developments
Table 44. Roche Company Information, Head Office, Market Area, and Industry Position
Table 45. Roche PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications, and Application
Table 46. Roche PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Roche Company Profile and Main Business
Table 48. Roche Recent Developments
Table 49. AstraZeneca Company Information, Head Office, Market Area, and Industry Position
Table 50. AstraZeneca PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications, and Application
Table 51. AstraZeneca PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. AstraZeneca Company Profile and Main Business
Table 53. AstraZeneca Recent Developments
Table 54. Ono Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 55. Ono Pharmaceutical PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications, and Application
Table 56. Ono Pharmaceutical PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Ono Pharmaceutical Company Profile and Main Business
Table 58. Ono Pharmaceutical Recent Developments
Table 59. Regeneron Company Information, Head Office, Market Area, and Industry Position
Table 60. Regeneron PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications, and Application
Table 61. Regeneron PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Regeneron Company Profile and Main Business
Table 63. Regeneron Recent Developments
Table 64. Innovent Company Information, Head Office, Market Area, and Industry Position
Table 65. Innovent PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications, and Application
Table 66. Innovent PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Innovent Company Profile and Main Business
Table 68. Innovent Recent Developments
Table 69. Hengrui Medicine Company Information, Head Office, Market Area, and Industry Position
Table 70. Hengrui Medicine PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications, and Application
Table 71. Hengrui Medicine PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Hengrui Medicine Company Profile and Main Business
Table 73. Hengrui Medicine Recent Developments
Table 74. Junshi Biosciences Company Information, Head Office, Market Area, and Industry Position
Table 75. Junshi Biosciences PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications, and Application
Table 76. Junshi Biosciences PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Junshi Biosciences Company Profile and Main Business
Table 78. Junshi Biosciences Recent Developments
Table 79. Merck KGaA Company Information, Head Office, Market Area, and Industry Position
Table 80. Merck KGaA PD-1/PD-L1 Inhibitors for Weight Loss Models, Specifications, and Application
Table 81. Merck KGaA PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Merck KGaA Company Profile and Main Business
Table 83. Merck KGaA Recent Developments
List of Figures
Figure 1. PD-1/PD-L1 Inhibitors for Weight Loss Picture
Figure 2. Global PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global PD-1/PD-L1 Inhibitors for Weight Loss Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value, (US$ million) & (2018-2029)
Figure 6. China PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity (K Units) & (2018-2029)
Figure 7. China PD-1/PD-L1 Inhibitors for Weight Loss Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China PD-1/PD-L1 Inhibitors for Weight Loss Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China PD-1/PD-L1 Inhibitors for Weight Loss Market Share of Global, 2018-2029
Figure 10. Global PD-1/PD-L1 Inhibitors for Weight Loss Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China PD-1/PD-L1 Inhibitors for Weight Loss Key Participants, Market Share, 2022
Figure 12. Global PD-1/PD-L1 Inhibitors for Weight Loss Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global PD-1/PD-L1 Inhibitors for Weight Loss Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global PD-1/PD-L1 Inhibitors for Weight Loss Production Market Share & Forecast by Region, 2018-2029
Figure 15. PD-1/PD-L1 Inhibitors for Weight Loss Industry Chain
Figure 16. PD-1/PD-L1 Inhibitors for Weight Loss Procurement Model
Figure 17. PD-1/PD-L1 Inhibitors for Weight Loss Sales Model
Figure 18. PD-1/PD-L1 Inhibitors for Weight Loss Sales Channels, Direct Sales, and Distribution
Figure 19. PD-1 Inhibitors
Figure 20. PD-L1 Inhibitors
Figure 21. By Type, Global PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value, 2018-2029, US$ Million
Figure 22. By Type, Global PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value Market Share, 2018-2029
Figure 23. By Type, Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, 2018-2029, (K Units)
Figure 24. By Type, Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity Market Share, 2018-2029
Figure 25. By Type, Global PD-1/PD-L1 Inhibitors for Weight Loss Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 26. Woman
Figure 27. Man
Figure 28. By Application, Global PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value, 2018-2029, US$ Million
Figure 29. By Application, Global PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value Market Share, 2018-2029
Figure 30. By Application, Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, 2018-2029, (K Units)
Figure 31. By Application, Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity Market Share, 2018-2029
Figure 32. By Application, Global PD-1/PD-L1 Inhibitors for Weight Loss Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 33. By Region, Global PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value Market Share, 2018-2029
Figure 34. By Region, Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity Market Share, 2018-2029
Figure 35. North America PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 36. By Country, North America PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value Market Share, 2022
Figure 37. Europe PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 38. By Country, Europe PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value Market Share, 2022
Figure 39. Asia Pacific PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 40. By Country/Region, Asia Pacific PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value Market Share, 2022
Figure 41. South America PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 42. By Country, South America PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value Market Share, 2022
Figure 43. Middle East & Africa PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 44. U.S. PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, 2018-2029, (K Units)
Figure 45. By Type, U.S. PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity Market Share, 2022 VS 2029
Figure 46. By Application, U.S. PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity Market Share, 2022 VS 2029
Figure 47. Europe PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, 2018-2029, (K Units)
Figure 48. By Type, Europe PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity Market Share, 2022 VS 2029
Figure 49. By Application, Europe PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity Market Share, 2022 VS 2029
Figure 50. China PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, 2018-2029, (K Units)
Figure 51. By Type, China PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity Market Share, 2022 VS 2029
Figure 52. By Application, China PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity Market Share, 2022 VS 2029
Figure 53. Japan PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, 2018-2029, (K Units)
Figure 54. By Type, Japan PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity Market Share, 2022 VS 2029
Figure 55. By Application, Japan PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity Market Share, 2022 VS 2029
Figure 56. South Korea PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, 2018-2029, (K Units)
Figure 57. By Type, South Korea PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity Market Share, 2022 VS 2029
Figure 58. By Application, South Korea PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity Market Share, 2022 VS 2029
Figure 59. Southeast Asia PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, 2018-2029, (K Units)
Figure 60. By Type, Southeast Asia PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity Market Share, 2022 VS 2029
Figure 61. By Application, Southeast Asia PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity Market Share, 2022 VS 2029
Figure 62. India PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, 2018-2029, (K Units)
Figure 63. By Type, India PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity Market Share, 2022 VS 2029
Figure 64. By Application, India PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity Market Share, 2022 VS 2029
Figure 65. Middle East & Africa PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, 2018-2029, (K Units)
Figure 66. By Type, Middle East & Africa PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity Market Share, 2022 VS 2029
Figure 67. By Application, Middle East & Africa PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity Market Share, 2022 VS 2029
Figure 68. Research Methodology
Figure 69. Breakdown of Primary Interviews
Figure 70. Bottom-up and Top-down Approaches
Figure 71. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|